BLOOD COUNTS THROUGH TREATMENT COURSE IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING CHEMORADIATION

被引：0

作者：

Deng, Davy ^{[1
]}

Hammoudeh, Lubna ^{[2
,3
]}

Cagney, Daniel ^{[2
,3
]}

McFaline-Figueroa, J. Ricardo ^{[4
]}

Chukwueke, Ugonma ^{[4
]}

Reardon, David ^{[4
]}

Lee, Eudocia Quant ^{[4
]}

Nayak, Lakshmi ^{[4
]}

Lim-Fat, Mary Jane ^{[5
]}

Ligon, Keith ^{[4
]}

Bi, Wenya Linda ^{[2
,3
]}

Arnaout, Omar ^{[2
,3
]}

Alexander, Brian ^{[2
,3
]}

Wen, Patrick ^{[6
]}

Rahman, Rifaquat ^{[2
,3
]}

机构：

[1] Harvard Sch Publ Hlth, Boston, MA USA

[2] Dana Farber, Boston, MA USA

[3] Brigham & Womens Canc Ctr, Boston, MA USA

[4] Dana Farber Canc Inst, Boston, MA USA

[5] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada

[6] Dana Farber Canc Inst, Ctr NeuroOncol, Boston, MA USA

来源：

NEURO-ONCOLOGY | 2021年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

BIOM-30

引用

页码：17 / 17

页数：1

共 50 条

[1] EVALUATING LYMPHOCYTE COUNTS IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING CHEMORADIATION
Hammoudeh, Lubna
Lim-Fat, Mary Jane
Cagney, Daniel
Aizer, Ayal A.
Tanguturi, Shyam
Arvold, Nils
Mcfaline-Figueroa, Jose
Chukwueke, Ugonma
Reardon, David
Lee, Eudocia
Nayak, Lakshmi
Rinne, Mikael
Ligon, Keith
Wen, Patrick
Alexander, Brian
Rahman, Rifaquat
NEURO-ONCOLOGY, 2020, 22 : 186 - 187
[2] The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma
Han, Seunggu J.
Rutledge, W. Caleb
Molinaro, Annette M.
Chang, Susan M.
Clarke, Jennifer L.
Prados, Michael D.
Taylor, Jennie W.
Berger, Mitchel S.
Butowski, Nicholas A.
NEUROSURGERY, 2015, 77 (02) : 248 - 253
[3] THE ASSOCIATIONS BETWEEN TOTAL LYMPHOCYTE COUNTS AFTER CONCOMITANT CHEMORADIATION WITH OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Ahn, Stephen
Park, Jae-Sung
Hong, Yong Kil
Yang, Seung Ho
Jeun, Sin-Soo
NEURO-ONCOLOGY, 2019, 21 : 9 - 9
[4] Treatment for Patients With Newly Diagnosed Glioblastoma
Chamberlain, Marc C.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (21): : 2348 - 2348
[5] The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma COMMENT
Schiff, David
NEUROSURGERY, 2015, 77 (02) : 253 - 253
[6] The informational needs of newly diagnosed cervical cancer patients who will be receiving combined chemoradiation treatment
Toubassi, Diana
Himel, Danielle
Winton, Susan
Nyhof-Young, Joyce
JOURNAL OF CANCER EDUCATION, 2006, 21 (04) : 263 - 268
[7] MRI Changes in Newly Diagnosed Glioblastoma During Treatment with Chemoradiation and Adjuvant Temozolomide
Ly, Ina
Ou, Yangming
Da, Xiao
Batchelor, Tracy
Kalpathy-Cramer, Jayashree
Gerstner, Elizabeth
NEUROLOGY, 2016, 86
[8] The course of quality of life and neurocognition in newly diagnosed patients with glioblastoma
Flechl, B.
Sax, C.
Ackerl, M.
Crevenna, R.
Woehrer, A.
Hainfellner, J.
Preusser, M.
Widhalm, G.
Kiesel, B.
Lutgendorf-Caucig, C.
Dieckmann, K.
Steffal, C.
Marosi, C.
Hassler, M. R.
RADIOTHERAPY AND ONCOLOGY, 2017, 125 (02) : 228 - 233
[9] Standard 6-week chemoradiation for elderly patients with newly diagnosed glioblastoma
Vaugier, Loig
Ah-Thiane, Loic
Aumont, Maud
Jouglar, Emmanuel
Campone, Mario
Colliard, Camille
Doucet, Ludovic
Frenel, Jean-Sebastien
Gourmelon, Carole
Robert, Marie
Martin, Stephane-Andre
Riem, Tanguy
Roualdes, Vincent
Campion, Loic
Mervoyer, Augustin
SCIENTIFIC REPORTS, 2021, 11 (01)
[10] Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma
Blakeley, Jaishri O.
Grossman, Stuart A.
Chi, Andrew S.
Mikkelsen, Tom
Rosenfeld, Myrna R.
Ahluwalia, Manmeet S.
Nabors, L. Burt
Eichler, April
Ribas, Ignacio Garcia
Desideri, Serena
Ye, Xiaobu
CLINICAL CANCER RESEARCH, 2019, 25 (01) : 73 - 79

← 1 2 3 4 5 →